Chronic Noncancer Pain Clinical Trial
Official title:
An Integrative and Sustainable Approach to Pain Management in Primary Care
The purpose of this study is to assess the impact of clinician education, electronic health record integrated patient reported outcomes, and electronic health record integrated decision support on pain-related care quality, outcomes, and service utilization.
The initiative has three components to aid clinicians' care of patients with chronic
noncancer pain: (1) education, (2) standardized patient reported outcomes data collection,
and (3) evidence-based brief treatment reminders. Practices will be randomized to either
receive the three novel components (treatment group) or continue with usual care (control
group).
Providers in the treatment group will be asked (a) to complete a series of six online
education modules in pain care, (b) will be given access to new patient reported outcomes
questionnaire data collected from patients within the electronic health record, (c) asked to
review this data and related care recommendations during the patient visit, and (d) asked to
complete baseline and monthly online surveys related to experiences and satisfaction with
providing care to patients with chronic noncancer pain.
Providers in the control group will provide care as usual to patients and will be asked to
complete baseline and monthly online surveys related to experiences and satisfaction with
providing care to patients with chronic noncancer pain.
Primary study outcomes include comparison of treatment and control group provider and
patient satisfaction surveys. Secondary outcome measures include provider referral rates,
patient outcomes, patient treatments recommended/ordered, and patient service
utilization/costs.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01428583 -
Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain
|
Phase 3 | |
Completed |
NCT03161795 -
Addressing the Risks of Long-Term Opioid Therapy in Chronic Noncancer Pain
|